These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6321687)

  • 61. Hypovascular hepatocellular carcinoma undetected at angiography and CT with iodized oil.
    Yoshimatsu S; Inoue Y; Ibukuro K; Suzuki S
    Radiology; 1989 May; 171(2):343-7. PubMed ID: 2539607
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CT diagnosis of early hepatocellular carcinoma: sensitivity, findings, and CT-pathologic correlation.
    Takayasu K; Furukawa H; Wakao F; Muramatsu Y; Abe H; Terauchi T; Winter TC; Sakamoto M; Hirohashi S
    AJR Am J Roentgenol; 1995 Apr; 164(4):885-90. PubMed ID: 7726041
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Small hepatocellular carcinomas: two-phase dynamic incremental CT in detection and evaluation.
    Ohashi I; Hanafusa K; Yoshida T
    Radiology; 1993 Dec; 189(3):851-5. PubMed ID: 8234715
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Utility of non-contrast-enhanced CT for improved detection of arterial phase hyperenhancement in hepatocellular carcinoma.
    Hennedige T; Yang ZJ; Ong CK; Venkatesh SK
    Abdom Imaging; 2014 Dec; 39(6):1247-54. PubMed ID: 24943135
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Outcome of small (10-20 mm) arterial phase-enhancing nodules seen on triphasic liver CT in patients with cirrhosis or chronic liver disease.
    O'Malley ME; Takayama Y; Sherman M
    Am J Gastroenterol; 2005 Jul; 100(7):1523-8. PubMed ID: 15984975
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Lobar attenuation difference of the liver on computed tomography.
    Nishikawa J; Itai Y; Tasaka A
    Radiology; 1981 Dec; 141(3):725-8. PubMed ID: 6272353
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Using contrast-enhanced sonography to assess the effectiveness of transcatheter arterial embolization for hepatocellular carcinoma.
    Numata K; Tanaka K; Kiba T; Saito S; Isozaki T; Hara K; Morimoto M; Sekihara H; Yonezawa H; Kubota T
    AJR Am J Roentgenol; 2001 May; 176(5):1199-205. PubMed ID: 11312181
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lipiodol trans-arterial chemoembolization of hepatocellular carcinoma with idarubicin: first experience.
    Favelier S; Boulin M; Hamza S; Cercueil JP; Cherblanc V; Lepage C; Hillon P; Chauffert B; Krausé D; Guiu B
    Cardiovasc Intervent Radiol; 2013 Aug; 36(4):1039-46. PubMed ID: 23224215
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hepatocellular carcinoma supplied from the short gastric artery: treatment with chemoembolization.
    Jeon UB; Lee JW; Baik SK; Kim TU; Choo KS; Kim KI; Kim YW; Moon TY
    Cardiovasc Intervent Radiol; 2012 Dec; 35(6):1512-4. PubMed ID: 22532333
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Experimental evaluation of five liver-spleen specific CT contrast agents.
    Miller DL; O'Leary T; Vucich JJ; Girton M; Vermess M; Doppman JL
    J Comput Assist Tomogr; 1983 Dec; 7(6):1022-8. PubMed ID: 6313773
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Use of intravenous liposoluble contrast material for the examination of the liver and spleen in lymphoma.
    Vermess M; Bernardino ME; Doppman JL; Fisher RI; Thomas JL; Velasquez WS; Fuller LM; Russo A
    J Comput Assist Tomogr; 1981 Oct; 5(5):709-13. PubMed ID: 6271856
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hepatoma in a young adult: to biopsy or not to biopsy?
    Brenner C; Amin Z; Wotherspoon AC; Vlavianos P; Andreyev J
    Gut; 2003 Jun; 52(6):905-6. PubMed ID: 12740352
    [No Abstract]   [Full Text] [Related]  

  • 73. New contrast material improves detection of liver and spleen metastases.
    Vermess M
    JAMA; 1984 Feb; 251(6):707-8. PubMed ID: 6319768
    [No Abstract]   [Full Text] [Related]  

  • 74. CT of retroperitoneal extension of hepatoma mimicking adrenal tumor.
    Kim KW; Auh YH; Chi HS; Lee SI
    J Comput Assist Tomogr; 1993; 17(4):599-602. PubMed ID: 8392525
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hepatoma presenting as a cerebellar metastasis.
    Brunner DR; Dunne MG; Rao KC; Sutherland JC; Cisternino SJ
    J Comput Tomogr; 1982 Apr; 6(1):65-8. PubMed ID: 6284441
    [No Abstract]   [Full Text] [Related]  

  • 76. Radiographic blood pool contrast agents for vascular and tumor imaging with projection radiography and computed tomography.
    Cassel DM; Young SW; Brody WR; Muller HH; Hall AL
    J Comput Assist Tomogr; 1982 Feb; 6(1):141-6. PubMed ID: 6279714
    [TBL] [Abstract][Full Text] [Related]  

  • 77. CT of the liver with intravenous lipoid contrast material: review of the current status.
    Vermess M; Doppman JL
    Semin Roentgenol; 1983 Apr; 18(2):102-5. PubMed ID: 6306836
    [No Abstract]   [Full Text] [Related]  

  • 78. Development and experimental evaluation of a contrast medium for computed tomographic examination of the liver and spleen.
    Vermess M; Chatterji DC; Doppman JL; Grimes G; Adamson RH
    J Comput Assist Tomogr; 1979 Feb; 3(1):25-31. PubMed ID: 217896
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Fusing Positive and Negative CT Contrast Nanoagent for the Sensitive Detection of Hepatoma.
    Meng X; Gao J; Sun Y; Duan F; Chen B; Lv G; Li H; Jiang X; Wu Y; Zhang J; Fang X; Yao Z; Zuo C; Bu W
    Adv Sci (Weinh); 2023 Dec; 10(34):e2304668. PubMed ID: 37870166
    [TBL] [Abstract][Full Text] [Related]  

  • 80. CT scanning for radiation therapy treatment planning of hepatoma.
    Rostock RA; Fishman EK; Order SE
    Int J Radiat Oncol Biol Phys; 1985 Jul; 11(7):1413-8. PubMed ID: 2989232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.